DTU Logo

Welcome to the Diabetes Trials Unit

The Diabetes Trials Unit (DTU) is a fully registered UKCRC Clinical Trials Unit, specialising in performing national and multinational clinical trials related to diabetes, and a member of the Oxford Clinical Trials consortium.

[More about the DTU]

Get Involved

To find out more about studies taking place see our multicentre or Oxford based Trials

To hear more about what it is like to take part in a diabetes research study watch our video

If you would like to take part in one of our studies or find out more, please complete our enquiry form.

Latest News

Precision medicine study reveals how our genetics can alter action of metformin, the most commonly used Type 2 diabetes drug

09-Aug-2016
News Image RDM researchers have uncovered new genetic evidence of how the benefits of the world's most commonly used Type 2 diabetes drug may vary between individuals.

Metformin, a drug used by hundreds of millions of people with Type 2 diabetes worldwide, has been in use for over 50 years....

[Read more...]

Toward Fairness in Data Sharing

04-Aug-2016
News Image The International Consortium of Investigators for Fairness in Trial Data Sharing have published a response to the The International Committee of Medical Journal Editors (ICMJE) proposed plan for sharing data from randomized, controlled trials (RCTs). This plan will require, as a condition of acceptance of trial results for publication, that authors make publicly available the deidentified individual patient data underlying the analyses reported in an article....

[Read more...]

Academy of Medical Sciences Clinical Lecturers Starter Grant

20-Jul-2016
News Image Dr Samiul Mostafa, DTU Honorary Clinical Lecturer, has received funding from The Academy of Medical Sciences for his project “Determining the “sweet-spots” for cardiovascular risk factors in Type 2 Diabetes Mellitus”

[More news]

This unit receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.